diosgenin has been researched along with Hemorrhage in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, J; Huang, W; Ji, C; Ma, L; Niu, H; Qin, C; Wang, H; Wei, Z; Xin, G; Xing, Z; Zheng, H | 1 |
1 other study(ies) available for diosgenin and Hemorrhage
Article | Year |
---|---|
The diosgenin prodrug nanoparticles with pH-responsive as a drug delivery system uniquely prevents thrombosis without increased bleeding risk.
Topics: Animals; Diosgenin; Drug Delivery Systems; Fibrinolytic Agents; Hemorrhage; Hepatocytes; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Micelles; Nanoparticles; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis | 2018 |